In order to synthesize human erythropoietin protein in the oviduct of laying hens, localized in vivo gene transfer was attempted by using electroporation. In Experiment 1, transcriptional activities were compared by using four viral and cellular promoters, i.e., the 1.35-kbp long ovalbumin promoter, SV40 early promoter, Rous sarcoma virus long terminal repeat (RSV LTR), and the miw promoter, which is a hybrid of RSV LTR and chicken b-actin promoter. These promoters were fused immediately upstream to the chloramphenicol acetyltransferase reporter gene. The results of chloramphenicol acetyltransferase activity showed that the miw promoter was the strongest, followed by SV40, RSV LTR, and the ovalbumin promoter in decreasing order. The intensity of the miw promoter was 250 times as high as that of the ovalbumin promoter. In Experiment 2, plasmid DNA containing the human erythropoietin gene, driven either by the ovalbumin promoter or the miw promoter, was transfected in vivo, and the production of human erythropoietin protein was detected by ELISA. The results indicated that the synthesis of human erythropoietin protein was attained in the chicken oviduct, and its concentration was higher when driven by the miw promoter than the ovalbumin promoter.
INTRODUCTION
Erythropoietin (EPO) is known as a principal glycoprotein hormone that stimulates erythropoiesis (Gesundheit and Alexander, 1994) . The synthesis of EPO in adult humans occurs mainly in the kidney (Jacobson et al., 1986) . In patients with chronic renal failure, administration of EPO can boost hematocrit values and prevent both anemia and the need for transfusion (Eschbach et al., 1987) .
Recently, production of recombinant EPO for a therapeutic purpose was attained in cultured cell lines such as Chinese hamster ovary cells (Lin et al., 1985) and baby hamster kidney cells (Tsuda et al., 1990) . We have also succeeded in expressing human EPO gene transcripts in primary cultures of chicken oviduct cells in vitro (unpublished results). However, the level of gene expression in chicken oviduct cells was not sufficient to give detectable levels of erythropoietin protein by ELISA.
One of the possible methods for foreign protein production is to apply in vivo gene transfer to tissues of living animals. For example, in the goat mammary gland, human growth hormone was produced after in vivo gene transfer using a retroviral vector (Archer et al., 1994) . Because of safety concerns, however, nonviral methods would be preferred under practical and experimental conditions. Of a variety of nonviral gene transfection methods, in vivo electroporation provides a simple and convenient means of gene transfer, in principle, to any type of dividing or nondividing cell in vivo (Muramatsu et al., 1996 (Muramatsu et al., , 1997a . The present study was conducted, therefore, to examine the possibility of transferring and expressing a gene encoding human EPO in the oviduct of laying hens by using a new transfection technology, in vivo electroporation.
MATERIALS AND METHODS

Experimental Animals
Single Comb White Leghorn laying hens at 17 mo of age, having an average egg production rate of about 70%, were used throughout the experiments. They were cared
Plasmid DNA
In Experiment 1, in which the promoter activity was compared, four different viral and cellular promoters were fused immediately upstream of the chloramphenicol acetyltransferase (CAT) reporter gene. They were: the chicken ovalbumin 5′-flanking promoter region extending from -1.35 to 0.01 kbp (OV-1.35, corresponding plasmid was pOVCAT-1.35); the SV40 early promoter and enhancer (pSVCAT); the Rous sarcoma virus long terminal repeat (RSV LTR) (pRSVCAT); and the miw promoter (Suemori et al., 1990) containing both the RSV LTR and the chicken b-actin promoter (pmiwCAT). In addition to these, the plasmid DNA, in which the miw promoter was fused immediately upstream to the firefly luciferase reporter gene, was also used for adjusting transfection efficiency.
In Experiment 2, the 840-bp full length human erythropoietin cDNA derived from pZipNeoSV(X)EPO (Okano et al., 1994) was isolated by Sau3AI digestion, and the human EPO cDNA was fused immediately down stream to either the OV-1.35 or miw promoter to construct the EPO expression plasmid DNA, pOVEPO-1.35, and pmiwEPO. These plasmid DNA were transfected in vivo together with pmiwluc for monitoring the success of the transfection procedure.
In Vivo Electroporation
The laying hens were lightly anesthetized with diethylether. The abdominal cavity was opened surgically, and the magnum portion of the oviduct was exposed. An incision of approximately 3 cm long was made longitudinally in the exposed magnum portion. Into one of the oviduct mucosal folds, filled with glandular cells on the mucosa side, 100 mL of DNA solution (5 mM CaCl 2 in 0.85% (wt/vol) NaCl) containing 100 mg of pmiwCAT, or equal moles of other plasmids was carefully injected together with 100 mg pmiwluc to correct transfection efficiency in Experiment 1, and 200 mg of pmiwEPO or equal moles of pOVEPO-1.35 with pmiwluc at 50 mg in Experiment 2. After injection, electric square pulses were applied eight times at 50V for the loading period of 50 ms per pulse with an electro-square porator T820. 2 Pulses were administered to the tissue using a tweezers type electrode. After 48 h, the hens were euthanatized and the oviduct portions were removed quickly.
Chemical Analysis
The oviduct samples were transferred to a 5-mL centrifuge tube to which 10 vol of ice-cold buffer A (15 mM Tris, 60 mM KCl, 15 mM NaCl, 12 mM EDTA, 1 mM dithiothreitol, 0.15 mM spermine, and 0.4 mM phenylmethylsulfonyl fluoride, pH adjusted to 7.6; Pothier et al., 1992) were added. After homogenization and sonication, the homogenate was centrifuged at 1,000 × g for 10 min. The supernatant was transferred to a new tube, and an aliquot of 20 mL was used for luciferase assay. The remaining cell extract was heated at 70 C for 3 h to inactivate endogenous acetylases, and pelleted by centrifugation at 1,000 × g for 10 min. The CAT activities were determined as described previously (van der Eb and Graham, 1980; Sanders and McKnight, 1988) , and the values were expressed as relative CAT activity after the adjustment for luciferase activities to take account of changes in transfection efficiency. The luciferase activity was determined by using a Pica Gene kit 3 according to the instruction given by the manufacturer. The human EPO protein was determined by amplified ELISA method (Okano et al., 1994) .
The EPO and mRNA concentration was also determined in Experiment 2 by RNA:RNA solution hybridization as described previously (Muramatsu et al., 1994) . For RNA:RNA solution hybridization, the EPO riboprobe was prepared from the bottom strand of 840-bp DNA sequences encoding the aforementioned full-length human erythropoietin cDNA derived form pZipNeoSV(X)EPO. The full length EPO cDNA was isolated by Sau3AI digestion, and subcloned into the multiple cloning site of pGEM-11Zf(-) cloning vector 4 to give pGEPO2, from which the EPO antisense RNA was transcribed in vitro.
Statistical Analysis
The data of CAT activities were analyzed by ANOVA after transforming to natural logarithmic values to stabilize error variance, and significance of the differences among the mean values was tested by Duncan's multiple range test by using General Linear Model procedures of SAS ® (SAS Institute, 1985) .
RESULTS AND DISCUSSION
The relative intensity of transcriptional activity of the four different promoters is given in Figure 1 . The cellular promoter, chicken ovalbumin 5′-flanking region extending from -1.35 to +0.01 kbp, had the lowest CAT expression compared with the three other promoters (P < 0.05). The CAT expression derived from the miw promoter, consisting of both RSV-LTR and chicken bactin promoters, was the highest among viral promoters tested, followed by the SV40 promoter, and the RSV promoter in decreasing order (P < 0.05).
The chicken ovalbumin and miw promoters were the weakest and strongest in the oviduct of living chickens, respectively. The human EPO gene was expressed in In all transfection samples, pmiwluc was co-transfected as internal control to normalize transfection efficiency. CAT activities were measured at 48 h after transfection. Statistical analysis was done after natural logarithmic transformation of the data to stabilize error variance. Values are means ± SEM of 7 replicates. Bars with no common letters are significantly different at P < 0.05.
TABLE 1. In vivo expression of the human erythropoietin (EPO)
gene and the EPO transcripts in the oviduct of laying hens 1 1 Plasmid DNA were transfected by in vivo electroporation to the oviduct of laying hens at a dose of 200 mg, and gene expression was determined at 48 h after transfection. ND; not detectable (< 0.1 pg/mL for EPO mRNA, and < 0.2 mU/mL for EPO).
2 Determined by RNA:RNA solution hybridization (Muramatsu et al., 1994) .
3 Determined by amplified ELISA (Okano et al., 1994 vivo together with the firefly luciferase gene. Three luciferase-positive samples were pooled to determine EPO mRNA and EPO protein concentrations (Table 1) . As might be expected, EPO protein concentration was higher in the oviduct transfected in vivo with pmiwEPO than with pOVEPO-1.35, and the EPO mRNA concentration showed the same trend. It has been recognized that DNA transfection to tubular gland cells from laying hens is difficult, if not virtually impossible, although the cells are abundant and available in the fully developed magnum segment of the laying hen's oviduct. We have previously used a gene-gun procedure to transfect foreign genes to cultured oviduct cells from laying hens, and clear signals of reporter proteins were observed (unpublished results). However, the gene-gun procedure was not efficient for in vivo expression of human EPO protein in the oviduct of living hens, as no detectable EPO protein was obtained (data not shown). Compared with the gene-gun method, in vivo electroporation was found to be equally or more efficient in the chicken embryo (Muramatsu et al., 1997b) , and the mouse testis (Muramatsu et al., 1996 (Muramatsu et al., , 1997a . Therefore, this new technology of localized in vivo gene transfer was tested in the present study.
For expressing foreign genes in the oviduct of living hens, the miw promoter was found to be most suitable (Figure 1) . By means of in vivo gene electroporation with the strongest promoter, human EPO gene was clearly expressed in oviductal cells from laying hens in the present study. However, neither the presence of sugar chain nor the biological activity of the human EPO protein could be determined, as the gene expression level was not sufficient to allow the above analysis. As a host tissue for human EPO production, the present in vivo gene expression system in the chicken oviduct may have to be further improved before making any comparison with other animal cell sources such as Chinese hamster ovary cells (Lin et al., 1985) or baby hamster kidney cells (Tsuda et al., 1990) .
